Quantitative proton nuclear magnetic resonance method for simultaneous analysis of fluticasone propionate and azelastine hydrochloride in nasal spray formulation

被引:11
作者
El-Masry, Amal A. [1 ]
El-Wasseef, Dalia R. [1 ,3 ]
Eid, Manal [2 ]
Shehata, Ihsan A. [1 ]
Zeid, Abdallah M. [2 ]
机构
[1] Mansoura Univ, Dept Med Chem, Mansoura 35516, Egypt
[2] Mansoura Univ, Fac Pharm, Dept Pharmaceut Analyt Chem, Mansoura 35516, Egypt
[3] Delta Univ Sci & Technol, Fac Pharm, Dept Pharmaceut Chem, Gamasa 35712, Egypt
来源
ROYAL SOCIETY OPEN SCIENCE | 2021年 / 8卷 / 07期
关键词
H-1-qNMR; fluticasone propionate; azelastine hydrochloride; nasal spray formulation; DRUG AZELASTINE; SALMETEROL XINAFOATE; QUALITY-CONTROL; HUMAN PLASMA; PURE FORM; STABILITY; IDENTIFICATION; SAMPLES; MS/MS; EYE;
D O I
10.1098/rsos.210483
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
A facile, rapid, accurate and selective quantitative proton nuclear magnetic resonance (H-1-qNMR) method was developed for the simultaneous determination of fluticasone propionate (FLP) and azelastine hydrochloride (AZH) in pharmaceutical nasal spray for the first time. The H-1-qNMR analysis of the studied analytes was performed using inositol as the internal standard and dimethyl sulfoxide-d(6) (DMSO-d(6)) as the solvent. The quantitative selective proton signal of FLP was doublet of doublet at 6.290, 6.294, 6.316 and 6.319 ppm, while that of AZH was doublet at 8.292 and 8.310 ppm. The internal standard (inositol) produced a doublet signal at 3.70 and 3.71 ppm. The method was rectilinear over the concentration ranges of 0.25-20.0 and 0.2-15.0 mg ml(-1) for FLP and AZH, respectively. No labelling or pretreatment steps were required for NMR analysis of the studied analytes. The proposed H-1-qNMR method was validated efficiently according to the International Council on Harmonisation guidelines in terms of linearity, limit of detection, limit of quantification, accuracy, precision, specificity and stability. Moreover, the method was applied to assay the analytes in their combined nasal spray formulation. The results ensured the linearity (r(2) > 0.999), precision (% RSD < 1.5), stability, specificity and selectivity of the developed method.
引用
收藏
页数:13
相关论文
共 51 条
  • [1] Abdel-Razeq SA., 2011, Sensing Electroanal, V6, P289
  • [2] Efficient UPLC and CE methods for the simultaneous determination of azelastine hydrochloride and its genotoxic impurity
    Abdelwahab, Nada S.
    Farid, Nehal F.
    Elagawany, Mohamed
    Abdelmomen, Esraa H.
    [J]. BIOMEDICAL CHROMATOGRAPHY, 2018, 32 (11)
  • [3] Quantitative 1H NMR spectroscopy
    Bharti, Santosh Kumar
    Roy, Raja
    [J]. TRAC-TRENDS IN ANALYTICAL CHEMISTRY, 2012, 35 : 5 - 26
  • [4] British Pharmacopoeia Commission, 2013, BRIT PHARM EL VERS
  • [5] Bunyavanich S., 2015, ALLERGY CLIN IMMUNOL, V1st edn, P36
  • [6] The determination of budesonide and fluticasone in human sputum samples collected from COPD patients using LC-MS/MS
    Buscher, B. A. P.
    Jagfeldt, H.
    Sandman, H.
    Brust-van Schaik, R.
    van Schaik, F.
    Brull, L. P.
    [J]. JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, 2012, 880 : 6 - 11
  • [7] Dave H., 2011, INT J APPL SCI ENG, V9, P177
  • [8] A rapid and sensitive HPLC-APCI-MS/MS method determination of fluticasone in human plasma: Application for a bioequivalency study in nasal spray formulations
    Duarte Byrro, Ricardo Martins
    Cesar, Isabela Costa
    de Santana e Silva Cardoso, Fabiana Fernandes
    Mundim, Iram Moreira
    Teixeira, Leonardo de Souza
    Bonfim, Ricardo Rodrigues
    Gomes, Sandro Antonio
    Pianetti, Gerson Antonio
    [J]. JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2012, 61 : 38 - 43
  • [9] Dubey R., 2013, Pharmbit, V27, P9
  • [10] Duran A, 2014, Drug Metab Lett, V8, P31